Status: current, Defined. Date: 31-Mar 2017. Module: Australian Medicines Terminology module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
1825901000168113 | Plasma-Lyte 148 (magnesium chloride hexahydrate 300 mg / 1 L + potassium chloride 370 mg / 1 L + sodium acetate trihydrate 3.68 g / 1 L + sodium chloride 5.26 g / 1 L + sodium gluconate 5.02 g / 1 L) intravenous infusion injection, 1 L bag (trade product unit of use) | en | Fully specified name | Inactive | Case sensitive | Australian Medicines Terminology module |
1825911000168111 | Plasma-Lyte 148 intravenous infusion injection, 1 L bag | en | Synonym | Inactive | Case sensitive | Australian Medicines Terminology module |
3134901000168110 | Plasma-Lyte 148 (magnesium chloride hexahydrate 300 mg / 1 L + potassium chloride 370 mg / 1 L + sodium acetate trihydrate 3.68 g / 1 L + sodium chloride 5.26 g / 1 L + sodium gluconate 5.02 g / 1 L) injection, 1 L bag (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
3134911000168113 | Plasma-Lyte 148 injection, 1 L bag | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Plasma-Lyte 148 injection, 1 L bag | has TPUU | True | Plasma-Lyte 148 injection, 1 L bag | Inferred relationship | Some | 1 |
Plasma-Lyte 148 injection, 1 L bag | has TPUU | True | Plasma-Lyte 148 injection, 1 L bag | Inferred relationship | Some | 1 |
Reference Sets
Trade product unit of use reference set